Hematology
Deferasirox PSK
Registration certificate:
INN:
Deferasirox
Release form:
Film-coated tablets
Therapeutic Area:
Hematology
Pharmacotherapeutic Group:
Complexing agent
Conditions for dispensing:
On prescription
Packaging:

Indications for Use:

Deferasirox PSK is intended for the treatment of adults and children aged 2 years and older with excessive iron levels in the blood following blood transfusions and similar procedures (chronic post-transfusion iron overload).

Deferasirox PSK is also intended for the treatment of adults and children aged 10 years and older with chronic post-transfusion iron overload.

This medication is included in the List of Essential Medicines.

Quality control
at all stages of production